SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?


To: MGV who wrote (1311)10/7/1999 1:27:00 PM
From: Charlie Smith  Read Replies (1) | Respond to of 1754
 
Mark:

Pricing issue is a red herring. From TLC's EPS report out an hour ago:

Actual average refractive net revenue after doctor compensation per procedure for the fiscal 2000 first quarter was US$1,368. This compares to an average of US$1,338 for the same period a year ago and up from US$1,288 for the previous quarter.

biz.yahoo.com

Stock is mooooving.

Charlie